First-trimester urine concentrations of phthalate metabolites and phenols and placenta miRNA expression in a cohort of U.S. women

Environmental Health Perspectives

Volumn 124, Issue 3, 2016, Pages 380-387

  LaRocca, Jessica ^b   Binder, Alexandra M ^b,c   McElrath, Thomas F ^b   Michels, Karin B ^a,b,c  

^a HARVARD UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ENDOCRINE DISRUPTOR; MICRORNA; PHENOL DERIVATIVE; PHTHALIC ACID; PHTHALIC ACID DERIVATIVE;

ARTICLE; COMPUTER MODEL; DNA SEQUENCE; FEMALE; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; HUMAN; KIDNEY CONCENTRATING CAPACITY; LIMIT OF DETECTION; NUCLEAR REPROGRAMMING; PILOT STUDY; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RNA PROCESSING; SENSITIVITY ANALYSIS; URINALYSIS; ADULT; COHORT ANALYSIS; GENE EXPRESSION REGULATION; METABOLISM; PLACENTA; PREGNANCY; URINE;

ADULT; COHORT STUDIES; ENDOCRINE DISRUPTORS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; PHENOLS; PHTHALIC ACIDS; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST;

EID: 84959272970     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1408409     Document Type: Article

References (62)

1. Adibi JJ, Whyatt RM, Hauser R, Bhat HK, Davis BJ, Calafat AM, et al. 2010. Transcriptional biomarkers of steroidogenesis and trophoblast differentiation in the placenta in relation to prenatal phthalate exposure. Environ Health Perspect. 118(2):291-296; doi:10.1289/ehp.0900788.
2. Adibi JJ, Whyatt RM, Williams PL, Calafat AM, Camann D, Herrick R, et al. 2008. Characterization of phthalate exposure among pregnant women assessed by repeat air and urine samples. Environ Health Perspect 116:467-473; doi:10.1289/ehp.10749.
3. Alexa A, Rahnenfuhrer J. 2010. topGO: topGO: Enrichment analysis for Gene Ontology. R package version 2.22.0.
4. Alexa A, Rahnenfuhrer J, Lengauer T. 2006. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 22:1600-1607; doi:10.1093/ bioinformatics/btl140.
5. Ambros V. 2004. The functions of animal microRNAs. Nature 431:350-355.
6. Avissar-Whiting M, Veiga KR, Uhl KM, Maccani MA, Gagne LA, Moen EL, et al. 2010. Bisphenol A exposure leads to specific microRNA alterations in placental cells. Reprod Toxicol 29:401-406.
7. Benachour N, Aris A. 2009. Toxic effects of low doses of bisphenol-A on human placental cells. Toxicol Appl Pharmacol 241:322-328.
8. Bernal AJ, Jirtle RL. 2010. Epigenomic disruption: the effects of early developmental exposures. Birth Defects Res A Clin Mol Teratol 88:938-944.
9. Birnbaum LS. 2013. State of the science of endocrine disruptors [Editorial]. Environ Health Perspect 121:A107; 10.1289/ehp.1306695.
10. Blair JD, Yuen RK, Lim BK, McFadden DE, von Dadelszen P, Robinson WP. 2013. Widespread DNA hypomethylation at gene enhancer regions in placentas associated with early-onset preeclampsia. Mol Hum Reprod 19:697-708.
11. Boas M, Feldt-Rasmussen U, Main KM. 2012. Thyroid effects of endocrine disrupting chemicals. Mol Cell Endocrinol 355:240-248.
12. Bollati V, Angelici L, Rizzo G, Pergoli L, Rota F, Hoxha M, et al. 2015. Microvesicle-associated microRNA expression is altered upon particulate matter exposure in healthy workers and in A549 cells. J Appl Toxicol 35:59-67.
13. Braun JM, Kalkbrenner AE, Calafat AM, Bernert JT, Ye X, Silva MJ, et al. 2011. Variability and predictors of urinary bisphenol A concentrations during pregnancy. Environ Health Perspect 119:131-137; doi:10.1289/ehp.1002366.
14. Braun JM, Smith KW, Williams PL, Calafat AM, Berry K, Ehrlich S, et al. 2012. Variability of urinary phthalate metabolite and bisphenol A concentrations before and during pregnancy. Environ Health Perspect 120:739-745; doi:10.1289/ehp.1104139.
15. Chevrier J, Gunier RB, Bradman A, Holland NT, Calafat AM, Eskenazi B, et al. 2013. Maternal urinary bisphenol A during pregnancy and maternal and neonatal thyroid function in the CHAMACOS study. Environ Health Perspect 121:138-144; doi:10.1289/ ehp.1205092.
16. Colborn T, vom Saal FS, Soto AM. 1993. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101:378-384.
17. Colomiere M, Permezel M, Riley C, Desoye G, Lappas M. 2009. Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. Eur J Endocrinol 160:567-578.
18. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap LC III, Wenstrom KD. 2005. Williams Obstetrics. 22nd ed. New York:McGraw-Hill.
19. Doshi T, D'souza C, Vanage G. 2013. Aberrant DNA methylation at Igf2-H19 imprinting control region in spermatozoa upon neonatal exposure to bisphenol A and its association with post implantation loss. Mol Biol Rep 40:4747-4757.
20. Dweep H, Sticht C, Pandey P, Gretz N. 2011. miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 44:839-847.
21. Fletcher T, Galloway TS, Melzer D, Holcroft P, Cipelli R, Pilling LC, et al. 2013. Associations between PFOA, PFOS and changes in the expression of genes involved in cholesterol metabolism in humans. Environ Int 57-58:2-10.
22. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. 2007. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27:91-105.
23. Haché S, Takser L, LeBellego F, Weiler H, Leduc L, Forest JC, et al. 2011. Alteration of calcium homeostasis in primary preeclamptic syncytiotrophoblasts: effect on calcium exchange in placenta. J Cell Mol Med 15:654-667.
24. Hornung RW, Reed LD. 1990. Estimation of average concentrations in the presence of nondetectable values. Appl Occup Environ Hyg 5:46-51.
25. Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH, et al. 2012. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 13:86; doi:10.1186/1471-2105-13-86.
26. Houseman EA, Molitor J, Marsit CJ. 2014. Referencefree cell mixture adjustments in analysis of DNA methylation data. Bioinformatics 30:1431-1439.
27. Irvin EA, Calafat AM, Silva MJ, Aguilar-Villalobos M, Needham LL, Hall DB, et al. 2010. An estimate of phthalate exposure among pregnant women living in Trujillo, Peru. Chemosphere 80:1301-1307.
28. Ishibashi O, Ohkuchi A, Ali MM, Kurashina R, Luo SS, Ishikawa T, et al. 2012. Hydroxysteroid (17-β) dehydrogenase 1is dysregulated by miR-210 and miR-518cthat are aberrantly expressed in preeclamptic placentas: a novel marker for predicting preeclampsia. Hypertension 59:265-273.
29. Jansson T, Powell TL. 2007. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci (Lond) 113:1-13.
30. Kim JH, Rozek LS, Soliman AS, Sartor MA, Hablas A, Seifeldin IA, et al. 2013. Bisphenol A-associated epigenomic changes in prepubescent girls: a crosssectional study in Gharbiah, Egypt. Environ Health 12:33; doi:10.1186/1476-069X-12-33.
31. Kundakovic M, Gudsnuk K, Franks B, Madrid J, Miller RL, Perera FP, et al. 2013. Sex-specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol A exposure. Proc Natl Acad Sci USA 110:9956-9961.
32. Langley-Evans SC, Alexander B, McArdle HJ, Sloboda DM. 2012. Developmental origins of health and disease. J Nutr Metab 2012:838640; doi:10.1155/2012/838640.
33. LaRocca J, Binder AM, McElrath TF, Michels KB. 2014. The impact of first trimester phthalate and phenol exposure on IGF2/H19genomic imprinting and birth outcomes. Environ Res 133:396-406.
34. Lesseur C, Armstrong DA, Paquette AG, Li Z, Padbury JF, Marsit CJ. 2014. Maternal obesity and gestational diabetes are associated with placental leptin DNA methylation. Am J Obstet Gynecol 211:654.e1-9; doi:10.1016/j.ajog.2014.06.037.
35. Lewis BP, Burge CB, Bartel DP. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20.
36. Maccani MA, Avissar-Whiting M, Banister CE, McGonnigal B, Padbury JF, Marsit CJ. 2010. Maternal cigarette smoking during pregnancy is associated with downregulation of miR-16, miR-21, and miR-146ain the placenta. Epigenetics 5:583-589.
37. Maccani MA, Padbury JF, Lester BM, Knopik VS, Marsit CJ. 2013. Placental miRNA expression profiles are associated with measures of infant neurobehavioral outcomes. Pediatr Res 74:272-278.
38. McElrath TF, Lim KH, Pare E, Rich-Edwards J, Pucci D, Troisi R, et al. 2012. Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. Am J Obstet Gynecol 207:407.e1-7; doi:10.1016/j.ajog.2012.08.010.
39. Meeker JD, Cantonwine DE, Rivera-González LO, Ferguson KK, Mukherjee B, Calafat AM, et al. 2013. Distribution, variability, and predictors of urinary concentrations of phenols and parabens among pregnant women in Puerto Rico. Environ Sci Technol 47:3439-3447.
40. Melzer D, Harries L, Cipelli R, Henley W, Money C, McCormack P, et al. 2011. Bisphenol A exposure is associated with in vivoestrogenic gene expression in adults. Environ Health Perspect 119:1788-1793; doi:10.1289/ehp.1103809.
41. Michels KB, Harris HR, Barault L. 2011. Birthweight, maternal weight trajectories and global DNA methylation of LINE-1 repetitive elements. PLoS One 6:e25254; doi:10.1371/journal.pone.0025254.
42. Morales-Prieto DM, Ospina-Prieto S, Schmidt A, Chaiwangyen W, Markert UR. 2014. Elsevier Trophoblast Research Award Lecture: origin, evolution and future of placenta miRNAs. Placenta 35(suppl):S39-S45.
43. Peck JD, Sweeney AM, Symanski E, Gardiner J, Silva MJ, Calafat AM, et al. 2010. Intra-and interindividual variability of urinary phthalate metabolite concentrations in Hmong women of reproductive age. J Expo Sci Environ Epidemiol 20:90-100.
44. Pitkin RM. 1985. Calcium metabolism in pregnancy and the perinatal period: a review. Am J Obstet Gynecol 151:99-109.
45. Rager JE, Moeller BC, Miller SK, Kracko D, DoyleEisele M, Swenberg JA, et al. 2014. Formaldehydeassociated changes in microRNAs: tissue and temporal specificity in the rat nose, white blood cells, and bone marrow. Toxicol Sci 138:36-46.
46. Rayman MP, Barlis J, Evans RW, Redman CW, King LJ. 2002. Abnormal iron parameters in the pregnancy syndrome preeclampsia. Am J Obstet Gynecol 187:412-418.
47. Richburg JH, Boekelheide K. 1996. Mono-(2-ethylhexyl) phthalate rapidly alters both Sertoli cell vimentin filaments and germ cell apoptosis in young rat testes. Toxicol Appl Pharmacol 137:42-50.
48. Silva MJ, Preau JL Jr, Needham LL, Calafat AM. 2008. Cross validation and ruggedness testing of analytical methods used for the quantification of urinary phthalate metabolites. J Chromatogr B Analyt Technol Biomed Life Sci 873:180-186.
49. Smith KW, Braun JM, Williams PL, Ehrlich S, Correia KF, Calafat AM, et al. 2012. Predictors and variability of urinary paraben concentrations in men and women, including before and during pregnancy. Environ Health Perspect 120:1538-1543; doi:10.1289/ ehp.1104614.
50. Susiarjo M, Sasson I, Mesaros C, Bartolomei MS. 2013. Bisphenol A exposure disrupts genomic imprinting in the mouse. PLoS Genet 9:e1003401; doi:10.1371/journal.pgen.1003401.
51. Swan SH. 2008. Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res 108:177-184.
52. Symonds ME, Stephenson T, Gardner DS, Budge H. 2007. Long-term effects of nutritional programming of the embryo and fetus: mechanisms and critical windows. Reprod Fertil Dev 19:53-63.
53. Takahashi O, Oishi S. 2000. Disposition of orally administered 2,2-bis(4-hydroxyphenyl)propane (bisphenol A) in pregnant rats and the placental transfer to fetuses. Environ Health Perspect 108:931-935.
54. Tetz LM, Cheng AA, Korte CS, Giese RW, Wang P, Harris C, et al. 2013. Mono-2-ethylhexyl phthalate induces oxidative stress responses in human placental cells in vitro. Toxicol Appl Pharmacol 268:47-54.
55. Tilghman SL, Bratton MR, Segar HC, Martin EC, Rhodes LV, Li M, et al. 2012. Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS One 7:e32754; doi:10.1371/journal. pone.0032754.
56. Veiga-Lopez A, Luense LJ, Christenson LK, Padmanabhan V. 2013. Developmental programming: gestational bisphenol-A treatment alters trajectory of fetal ovarian gene expression. Endocrinology 154:1873-1884.
57. Wang J, Zhang Y, Zhang W, Jin Y, Dai J. 2012. Association of perfluorooctanoic acid with HDL cholesterol and circulating miR-26b and miR-199-3p in workers of a fluorochemical plant and nearby residents. Environ Sci Technol 46:9274-9281.
58. Wang W, Feng L, Zhang H, Hachy S, Satohisa S, Laurent LC, et al. 2012. Preeclampsia up-regulates angiogenesis-associated microRNA (i.e., miR-17,-20a, and-20b) that target EPHRIN-B2 and EPHB4 in human placenta. J Clin Endocrinol Metab 97:E1051-E1059.
59. Wilhelm-Benartzi CS, Houseman EA, Maccani MA, Poage GM, Koestler DC, Langevin SM, et al. 2012. In uteroexposures, infant growth, and DNA methyl ation of repetitive elements and developmentally related genes in human placenta. Environ Health Perspect 120:296-302; doi:10.1289/ ehp.1103927.
60. Wolff MS, Engel SM, Berkowitz GS, Ye X, Silva MJ, Zhu C, et al. 2008. Prenatal phenol and phthalate exposures and birth outcomes. Environ Health Perspect 116:1092-1097; doi:10.1289/ehp.11007.
61. Woodruff TJ, Zota AR, Schwartz JM. 2011. Environ mental chemicals in pregnant women in the United States: NHANES 2003-2004. Environ Health Perspect 119:878-885; doi:10.1289/ ehp.1002727.
62. Ye X, Kuklenyik Z, Needham LL, Calafat AM. 2005. Automated on-line column-switching HPLC-MS/MS method with peak focusing for the determination of nine environmental phenols in urine. Anal Chem 77:5407-5413.